Stockholder’s Deficit (Tables)
|
6 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Sep. 30, 2025 |
| Equity [Abstract] |
|
|
| Schedule of stock option grant activity |
| Schedule of Black-Scholes model |
|
|
|
|
|
|
|
|
| |
|
January 2, 2026 - March 12, 2026 |
|
August 6, 2025 - September 2, 2025 |
| Exercise price |
|
|
$ 9.26 - 7.47 |
|
|
|
$ 3.27 - 9.09 |
|
| Risk-free interest rate |
|
|
3.74 - 3.84 |
% |
|
|
3.58 -3.91 |
% |
| Volatility |
|
|
73.0 - 86.3 |
% |
|
|
101.4 - 114.4 |
% |
| Expected life (years) |
|
|
4 - 4.5 |
|
|
|
3.19 - 5.00 |
|
| Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
The following is an analysis of the stock option grant activity:
| Schedule of stock option
grant activity | | |
| | | |
| | | |
| | |
| | |
Number | |
Weighted Average Exercise Price | |
Weighted Average Remaining Life |
| Outstanding at September 30, 2025 | | |
| — | | |
$ | — | | |
| — | |
| Granted | | |
| 6,850,000 | | |
| 7.42 | | |
| 5.23 | |
| Expired | | |
| — | | |
| — | | |
| — | |
| Exercised | | |
| — | | |
| — | | |
| — | |
| Outstanding at December 31, 2025 | | |
| 6,850,000 | | |
| 7.42 | | |
| 5.23 | |
| Granted | | |
| 1,000,000 | | |
| 8.37 | | |
| 5.00 | |
| Expired | | |
| — | | |
| — | | |
| — | |
| Forfeited | | |
| (3,600,000 | ) | |
| (8.04 | ) | |
| (4.38 | ) |
| Outstanding at March 31, 2026 | | |
| 4,250,000 | | |
| 7.75 | | |
| 5.85 | |
|
| Schedule
of Black-Scholes model | |
June
30,
2025 |
| Exercise
price | |
| 3.27
– 9.09 | |
| Risk-free
interest rate | |
| 3.58
– 3.91 | % |
| Volatility | |
| 101.4 – 114.4 | % |
| Expected
life (years) | |
| 3.19-5.00 | |
| Dividend
yield | |
$ | 0 | % |
The following is an analysis of the stock option grant
activity:
| Schedule
of stock option grant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number |
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Life |
| Outstanding at September 30,
2024 |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
| Granted |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at September 30,
2025 |
|
|
|
6,850,000 |
|
|
$ |
7.42 |
|
|
|
5.23 |
|
| Exercisable at September 30, 2025 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
| Schedule of stock option grant activity |
|
| Schedule
of stock option grant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number |
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Life |
| Outstanding at September 30,
2024 |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
| Granted |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at September 30,
2025 |
|
|
|
6,850,000 |
|
|
$ |
7.42 |
|
|
|
5.23 |
|
| Exercisable at September 30, 2025 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
| Schedule of recognize the remaining total stock-based compensation |
| Schedule of recognize the remaining total stock-based
compensation |
|
|
|
|
|
| Year |
|
Amount |
| 2026 |
|
|
$ |
2,450,154 |
|
| 2027 |
|
|
|
4,900,308 |
|
| 2028 |
|
|
|
4,900,308 |
|
| 2029 |
|
|
|
3,703,652 |
|
| 2030 |
|
|
|
265,026 |
|
| Total |
|
|
$ |
16,219,448 |
|
|
| Schedule
of recognize the remaining total stock-based compensation | | |
| | |
| Year | |
Amount |
| Remainder
of 2025 | | |
$ | 2,009,847 | |
| 2026 | | |
| 8,039,388 | |
| 2027 | | |
| 8,039,388 | |
| 2028 | | |
| 8,039,388 | |
| 2029 | | |
| 5,000,388 | |
| Total | | |
$ | 31,128,519 | |
|